Sickle Cell Trait in French West Indian Elite Sprint Athletes

Abstract

The aim of this study was to establish the percentage of sickle cell trait (SCT) carriers among French West Indian sprinters selected for the French National Team in 2000. The investigation determined the number of SCT carriers and the number of national records they had established. Sixteen athletes were indexed (6 males and 10 females). The athletes were within the ranges of 20 - 33 years, 161 - 186 cm and 60 - 80 kg. The results showed the presence of SCT carriers in this population among whom three were SCT carriers (2 males and 1 female) (18.75 %). Moreover, there is a significantly higher percentage of titles and records held by the SCT carriers (38.6 % and 50 %, respectively). In conclusion, this study shows that sickle cell trait carriers are able to perform sprint exercises at the highest levels, and it further indicates that brief and explosive exercise involving mainly the alactic anaerobic metabolism may be enhanced by HbS.

Sickle cell trait - sprint - anaerobic metabolism

References

• 1 Atkinson D W. Sickling and hematuria.  Blood. 1969;  34 736-737
• 2 Bile A, Le Gallais D, Mercier J, Bogui P, Préfaut C. Sickle cell trait in Ivory Coast athletic throw and jump champions, 1956 - 1995.  Int J Sports Med. 1998;  19 1-5
• 3 Bile A, Le Gallais D, Mercier J, Martinez P, Ahmaidi S, Préfaut C. Anaerobic exercise components during the force-velocity test in sickle cell trait.  Int J Sports Med. 1996;  17 254-258
• 4 Bitanga E, Rouillon J D. Influence of sickle cell trait heterozygote on energy abilities.  Pathol Biol. 1998;  46 46-52
• 5 Brooks G A, Fahey T D, White T P. Exercise Physiology. Human Bioenergetics and its Applications. 2nd ed. Mountain View; Mayfield Publishing Company 1996: 750
• 6 Edington G M, Lehman H. Expression of sickle cell gene in Africa.  Br Med J. 1955;  1 1308-1311
• 7 Etienne-Julan M. Drépanocytose en Guadeloupe: origine historique. Info drépano, CCD.  Medical Internal Review of Guadeloupe FWI. 1997;  4 (avril)
• 8 Embury S H, Dozy A M. The alpha gene genotype as a determinant of hematologic parameters in sickle cell trait. Sigler The Molecular Basis of Mutant Hemoglobin Dysfunction. North Holland; Elsevier 1981: 63
• 9 Fabritius H, Millan J, Defressigne Y. Recherche des hémoglobines anormales chez de jeunes recrues antillaises. Incidence et intérêt d'un dépistage systématique.  Med Armées. 1978;  6 199-205
• 10 Freund H, Lonsdorfer J, Oyono-Enguélé S, Lonsdorfer A, Bogui P. Lactate exchange and removal abilities in sickle cell trait carriers during and after incremental exercise.  Int J Sports Med. 1995;  16 428-434
• 11 Gima A S, Bemis E L. Absence of major illnesses in sickle cell trait: Results from a controlled study.  J Natl Med Assoc. 1975;  67 216-219
• 12 Higgs G R, Aldridge B E, Lamb J, Clegg J B, Weatherall D J, Hayes R J, Grandison Y, Lowrie Y, Mason K P, Serjeant B E, Serjeant G R. The interaction of alpha-thalassemia and homozygous cell disease.  N Engl J Med. 1982;  306 1441-1446
• 13 Hue O, Julan M E, Blonc S, Martin S T, Hertogh C, Marlin L, Pallud C, Le Gallais D. Alactic anaerobic performance in subjects with sickle cell trait and hemoglobin AA.  Int J Sports Med. 2002;  23 174-177
• 14 Hultman E, Sjöholm H. Energy metabolism and contraction force of human skeletal muscle in situ during electrical stimulation.  J Physiol. 1983;  345 525-532
• 15 Kark J A, Posey D M, Schumacher H R, Ruehle C J. Sickle cell trait as a risk factor for sudden death in physical training.  N Engl J Med. 1987;  317 781-787
• 16 Lebras M, Delmas M, Longy M, Jaubert D, Candito D. Les porteurs du trait drépanocytaire sont-ils asymptotiques?.  Med Trop. 1978;  38 161-165
• 17 Le Gallais D, Lonsdorfer J, Bogui P, Mercier J, Macabies J, Préfaut C. Trait drépanocytaire (AS) et performances en courses de vitesse, de résistance et d'endurance.  Sci Sports. 1989;  4 249-251
• 18 Le Gallais D, Préfaut C, Dulat C, Macabies J, Lonsdorfer J. Sickle cell trait in Ivory Coast athletic champions.  Int J Sports Med. 1991;  12 509-510
• 19 Le Gallais D, Préfaut C, Mercier J, Bile A, Bogui P, Lonsdorfer J. Sickle cell trait as a limiting factor for high-level performance in a semi-marathon.  Int J Sports Med. 1994;  15 399-402
• 20 Le Gallais D, Bile A, Mercier J, Paschel M, Tonellot J L, Dauverchain J. Exercise-induced death in sickle cell trait: role of aging, training and deconditioning.  Med Sci Sports Exerc. 1996;  28 541-544
• 21 Lonsdorfer J, Bogui P, Otayek A, Pigearias B, Boutros-Toni F, Cabannes R. Modifications du débit cardiaque dans les hémoglobinopathies à HbS.  Bull Europ Physiopath Resp. 1983;  19 374-375
• 22 Lonsdorfer J, Bogui P, Boutros-Toni F. Physiopathologie cardio-respiratoire dans les hémoglobinopathies à HbS.  Med Trop. 1986;  22 31-46
• 23 Mercier J, Mercier B, Prefaut C. Sollicitation du métabolisme anaérobie lactique lors de la répétition d'exercices brefs et intenses.  C R Soc Biol. 1989;  183 60-66
• 24 Murphy J R. Sickle cell hemoglobin (Hb AS) in black football players.  JAMA. 1973;  225 981-982
• 25 Robinson J R, Stone W J, Asendorf A C. Exercise capacity of black sickle cell trait males.  Med Sci Sports Exerc. 1976;  8 244-245
• 26 Serjeant B E, Mason K P, Kenny M W, Stuart J, Higgs D R, Weatherall D J, Hayes R J, Serjeant G R. Effect of alpha-thalassemia on rheology of homozygous sickle cell disease.  Br J Hematol. 1983;  55 479-486
• 27 Thiriet P, Monny Lobe M, Gweha I, Gozal D. Prevalence of the sickle cell trait in an athletic West African population.  Med Sci Sports Exerc. 1991;  23 389-390
• 28 Thiriet P, Le hersan J Y, Wouassi D, Bitanga E, Gozal D, Louis F J. Sickle cell performance in a prolonged race at high altitude.  Med Sci Sports Exerc. 1994;  26 914-918
• 29 Weisman I M, Zeballos J, Martin T W, Johnson B D. Effect of army basic training in sickle cell trait.  Arch Intern Med. 1988;  148 1140-1144